Merck Stirs Up the Takeover Talk
Is a new compensation plan for top execs in case of a deal or liquidation just a coincidence? The drugmaker says so
By Amy Barrett
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.